For the year ending 2025-12-31, MTVA has $11,123K in assets. $5,790K in debts. $10,278K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 10,278 | |||
| Prepaid expenses and other current assets | 597 | |||
| Total current assets | 10,875 | |||
| Property and equipment, net | 17 | |||
| Right-of-use asset | 210 | |||
| Other assets | 21 | |||
| Total assets | 11,123 | |||
| Accounts payable | 1,060 | |||
| Clinical trial accrued liabilities | 79 | |||
| Accrued expenses and other current liabilities | 993 | |||
| Warrant liabilities | 136 | |||
| Related party payable | 3,312 | |||
| Lease liability, short-term | 68 | |||
| Total current liabilities | 5,648 | |||
| Lease liability, long-term | 142 | |||
| Total liabilities | 5,790 | |||
| Common stock, 0.001 par value per share, 100,000,000 shares authorized as of december 31, 2025 and 2024 2,308,294 and 785,194 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 2 | |||
| Additional paid-in capital | 154,161 | |||
| Accumulated deficit | -148,830 | |||
| Total stockholders' equity | 5,333 | |||
| Total liabilities and stockholders' equity | 11,123 | |||
MetaVia Inc. (MTVA)
MetaVia Inc. (MTVA)